Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

For Better or Worse? On the Verge of a New Era in Investing

(The Global 7500 aircraft. Image via Bombardier Inc.) If there is one thing that we have learned one year into the COVID-19 pandemic, we must often take things as they come, week by week, especially in a volatile market. It's no April Fool's prank. Each week, w...
Stockhouse Editorial | March 31, 2021 |

Karyopharm Trades Up 60% on Positive Phase 3 Multiple Myeloma Results

Karyopharm Therapeutics shares set a new 52-week high price after the company reported that its Phase 3 BOSTON trial of XPOVIO® achieved significant increases in progression-free survival in patients suffering with multiple myeloma. Oncology-focused...
Streetwise Reports | March 3, 2020 |

Aleafia Health CEO Talks Expansion Plans and Progress

(Image via Aleafia Health. Click image to enlarge) When a business strategy works and can be expanded, the smart bet is to double down. That’s the logic in any industry, and the still-growing cannabis market is no different. That&CloseCurlyQuote...
Omri Wallach | September 27, 2019 |

Buzz on the Bullboards: T’is the Season for a Rebound?

(Image via SweetWater Brewing Co.) It happens every year, the mood among North American markets changes drastically once American Thanksgiving passes and despite a “socially distanced” holiday this year, that still holds true. Traders are ...
Stockhouse Editorial | December 2, 2020 |

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...
Streetwise Reports | April 7, 2020 |

Edesa Shares Double Upon Gaining Approval to Initiate Phase 2/3 COVID-19 Study

Shares of Edesa Biotech traded more than 100% higher after the company reported that it had received regulatory approval from Health Canada to initiate a Phase 2/3 study of its investigational drug EB05 in COVID-19. Clinical-stage biopharmaceutical company Edesa B...
Streetwise Reports | June 16, 2020 |

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...
Streetwise Reports | November 27, 2019 |

Arcadia Ropes in $3 Million in GoodHemp Seed Purchase Orders Within 50 Days of Product Launch

Arcadia Biosciences shares traded 25% higher after reporting that it secured $3 million in pre-season GoodHemp seed purchase commitments in just 50 days after launching the product. Arcadia Biosciences Inc. (RKDA:NASDAQ) , which employs science-based approac...
Streetwise Reports | January 31, 2020 |

Coronavirus Propels Telemedicine into the Spotlight

Summary: Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the '90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government...
Streetwise Reports | March 27, 2020 |

Buzz on the Bullboards: Top Healthcare and Tech

Nothing is spookier and scarier on Halloween than an uncertain market! That’s exactly what investors have been dealing with lately, and part of what we’ll try to demystify this week. Lots of companies have been moving independent of the...
Omri Wallach | October 30, 2019 |
1 2 3 4 5 6 7 8 9 10 ...